Target Classification for Thermotoga maritima Proteins

Target Classification for: Most Recent  20160824 - 20141229  20141022 - 20130107  20120316 - 20130206  20111007 - 20120418  20110207 - 20111005  20100723 - 20110202  20100721 - 20091118  20091118 - 20090702  20090722 - 20080409  20080423 - 20071010  20071010 - 20051101  

FFAS results of Thermotoga maritima vs COG0516  H.sapiens  HGM_OVER  JCSG0516  NEW_HUMAN_DOMAINS  PDB0516  PfamA30U  SCOP206  VFDB  All  

Target structural status listed by individual protein(new): please click here


Date 08_16_2017 08_09_2017 08_02_2017 07_26_2017 07_19_2017 07_12_2017 07_05_2017 06_28_2017 06_21_2017 06_14_2017 06_07_2017 05_31_2017 05_24_2017 05_17_2017 05_10_2017 05_03_2017 04_26_2017 04_19_2017 04_12_2017 04_05_2017 03_29_2017 03_22_2017 03_15_2017 03_08_2017 03_01_2017 02_22_2017 02_15_2017 02_08_2017 02_01_2017 01_25_2017 01_18_2017 01_11_2017 01_04_2017 12_28_2016 12_21_2016 12_14_2016 12_07_2016 11_30_2016 11_23_2016 11_16_2016 11_09_2016 11_02_2016 10_26_2016 10_19_2016 10_12_2016 10_05_2016 09_28_2016 09_21_2016 09_14_2016 09_07_2016 09_01_2016 05_16_2016
orphan 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%) 25(1.34%)
transmembrane proteins 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 332(17.74%) 333(17.79%)
low-complexity 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%) 50(2.67%)
orphan & transmembrane 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%) 5(0.27%)
low-complexity & transmembrane 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%) 84(4.49%)
orphan & low-complexity 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%) 1(0.05%)
orphan & transmembrane & low-complexity 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%)
no fold prediction 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 100(5.34%) 102(5.45%)
fold prediction only 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 147(7.85%) 146(7.80%)
possible MR targets 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 205(10.95%) 206(11.00%) 206(11.00%)
MR targets 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 533(28.47%) 532(28.42%) 531(28.37%)
in pdb 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 390(20.83%) 389(20.78%)

Orphan: no homologs in other organisms
Transmembrane Proteins:one or more transmembrane helixes predicted by TMHMM
Low-complexity Proteins: more than 40aa in low-complexity regions
No Fold Prediction: no siginificant ffas hit in PDB
Fold Prediction Only: ffas score < -9.5 minus "probable MR target", "MR target" and "in pdb"
Possible MR Targets: ffas score better than -15, coverage better than 50%, sequence identity > 20% minus "MR target" and "in pdb"
MR Targets: ffas score better than -15, coverage better than 50%, sequence identity > 30% minus "in pdb"
In PDB: sequence identity > 90%, coverage > 50%
The total number of T. Maritima proteins is 1872(After Jul. 2009), 1869(before Jul. 2009), 1859(Before Apr. 2007).